VITA-15- vita-15 injection 
Neogen Corporation

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

NeogenVet
Vita-15TM
Injection
Sterile Solution

Indications:

A source of nutritional factors for use in horses.

Each mL contains:

Pyridoxine HCl ...................................................... 10 mg
Riboflavin 5'-PO4-Na•2H2O USP .............................. 10 mg
d-Panthenol ......................................................... 15 mg
Niacinamide ....................................................... 100 mg
Inositol ............................................................... 10 mg
Choline Chloride ................................................... 10 mg
Biotin .................................................................. 10 mcg
L-Lysine HCl ......................................................... 20 mg
Glycine ................................................................ 20 mg
Cobalt Gluconate 8 H2O ......................................... 0.7 mg
Benzyl Alcohol ........................................................... 2%
Water for Injection .................................................... q.s.

Dosage & Administration:

Intramuscular or intravenous. Horse: 1 mL per 100 lbs
body weight. Repeat once or twice weekly or as indicated.

CAUTION:

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FOR VETERINARY USE ONLY

KEEP OUT OF REACH OF CHILDREN

AVOID EXPOSURE TO LIGHT

Store at refrigerated temperatures between 2° and 8°C (36° -46°F).

Item No. 08882

Made in the USA

Net Contents: 100 mL

Lot No.

Exp. Date:

Manufactured by: Nova-Tech, Grand Island, NE 68801
Manufactured for: Neogen Corporation, Lexington, KY 40511

859-254-1221

animalsafety.neogen.com

L112-0618

image description

VITA-15 
vita-15 injection
Product Information
Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:59051-8882
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE HYDROCHLORIDE10 mg  in 1 mL
RIBOFLAVIN 5'-PHOSPHATE SODIUM (UNII: 20RD1DZH99) (FLAVIN MONONUCLEOTIDE - UNII:7N464URE7E) FLAVIN MONONUCLEOTIDE10 mg  in 1 mL
DEXPANTHENOL (UNII: 1O6C93RI7Z) (DEXPANTHENOL - UNII:1O6C93RI7Z) DEXPANTHENOL15 mg  in 1 mL
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE100 mg  in 1 mL
INOSITOL (UNII: 4L6452S749) (INOSITOL - UNII:4L6452S749) INOSITOL10 mg  in 1 mL
CHOLINE CHLORIDE (UNII: 45I14D8O27) (CHOLINE - UNII:N91BDP6H0X) CHOLINE CHLORIDE10 mg  in 1 mL
BIOTIN (UNII: 6SO6U10H04) (BIOTIN - UNII:6SO6U10H04) BIOTIN10 ug  in 1 mL
LYSINE HYDROCHLORIDE (UNII: JNJ23Q2COM) (LYSINE - UNII:K3Z4F929H6) LYSINE20 mg  in 1 mL
GLYCINE (UNII: TE7660XO1C) (GLYCINE - UNII:TE7660XO1C) GLYCINE20 mg  in 1 mL
COBALTOUS GLUCONATE (UNII: 26SK597UWV) (COBALTOUS CATION - UNII:AI1MR454XG) COBALTOUS GLUCONATE0.7 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
BENZYL ALCOHOL (UNII: LKG8494WBH) 20 mg  in 1 mL
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:59051-8882-5100 mL in 1 VIAL, MULTI-DOSE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other06/22/201112/21/2023
Labeler - Neogen Corporation (042125879)
Registrant - Nova-Tech, Inc (196078976)
Establishment
NameAddressID/FEIBusiness Operations
Nova-Tech, Inc196078976manufacture

Revised: 12/2023
 
Neogen Corporation